MedTrace Logo

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

NCT01937338 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-05-07

No results posted yet for this study

Summary

Study to investigate the effect of a single dose of AZD7624 on inflammation caused by an endotoxin challenge.

Conditions

  • LPS Challenge, Neutrophils

Interventions

DRUG

AZD7624

nebuliser solution; 20 mg/mL for inhalation

DRUG

Placebo

nebuliser solution for inhalation

Sponsors & Collaborators

Principal Investigators

  • Saeed Khan, MBBS MRCP · Quintiles London, UK

  • Naimish Patel · AstraZeneca R&D Boston, United States

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01937338 on ClinicalTrials.gov